Gun Jörneskog Selected Research

Gun Jörneskog Research Topics

Disease

11	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021 - 09/2010
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2008
4	Ulcer 01/2012 - 03/2002
3	Inflammation (Inflammations) 10/2021 - 06/2015
3	Autoimmune Diseases (Autoimmune Disease) 10/2021 - 05/2016
3	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 10/2021 - 10/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 02/2012
3	Insulin Resistance 01/2020 - 01/2014
3	Chronic Renal Insufficiency 01/2019 - 01/2015
3	Foot Ulcer 01/2012 - 09/2003
2	Hyperemia 10/2021 - 10/2008
2	Diabetes Complications 01/2020 - 01/2020
2	Vascular Diseases (Vascular Disease) 01/2018 - 01/2007
2	Ischemic Stroke 10/2015 - 01/2014
2	Albuminuria 01/2012 - 01/2008
2	Peripheral Arterial Occlusive Disease 1 08/2011 - 09/2003
2	Diabetic Foot 01/2007 - 03/2002
1	Fatty Liver 10/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2021
1	Body Weight (Weight, Body) 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Atherosclerosis 01/2019
1	Ataxia (Dyssynergia) 01/2017
1	Graves Disease (Basedow Disease) 05/2016
1	Transient Ischemic Attack 10/2015
1	Cerebral Small Vessel Diseases 10/2015
1	Carotid Artery Diseases 10/2015
1	Acute Coronary Syndrome 09/2015
1	Glucose Intolerance 01/2014
1	Hyperthyroidism 12/2011
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 08/2011
1	Dyslipidemias (Dyslipidemia) 09/2010
1	Diabetes Mellitus 12/2009
1	Chronic Limb-Threatening Ischemia 07/2008
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2008

Drug/Important Bio-Agent (IBA)

5	FibrinIBA 02/2015 - 09/2010
4	Angiotensin IIIBA 10/2021 - 10/2008
4	Dalteparin (Dalteparin Sodium)FDA Link 01/2012 - 09/2003
3	Insulin (Novolin)FDA Link 10/2021 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2018
3	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2016 - 07/2014
3	Atorvastatin (Lipitor)FDA Link 11/2013 - 09/2010
2	AngiotensinsIBA 10/2021 - 01/2016
2	HMGB1 Protein (HMG1)IBA 12/2020 - 05/2016
2	P-SelectinIBA 05/2016 - 08/2011
2	Clopidogrel (Plavix)FDA Link 10/2015 - 01/2014
2	Thrombin FDA Link 06/2015 - 08/2011
2	LipidsIBA 11/2013 - 09/2010
2	Endothelin A ReceptorIBA 07/2008 - 01/2008
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	Exenatide (Byetta)FDA Link 01/2021
1	AlarminsIBA 12/2020
1	Pyruvic Acid (Pyruvate)IBA 01/2020
1	C-PeptideIBA 01/2020
1	ErythritolIBA 01/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2020
1	NucleotidesIBA 01/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	Thiamine MonophosphateIBA 01/2020
1	Interleukin-2 Receptor alpha SubunitIBA 01/2020
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2019
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 12/2018
1	PhosphatidylserinesIBA 12/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	Phosphates (Orthophosphate)IBA 01/2017
1	E-SelectinIBA 05/2016
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 05/2016
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 05/2016
1	AutoantibodiesIBA 05/2016
1	CD40 Ligand (CD40L)IBA 05/2016
1	C-Reactive ProteinIBA 01/2016
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2016
1	ReninIBA 01/2016
1	Fibrinolysin FDA Link 01/2016
1	paricalcitol (Zemplar)FDA Link 01/2015
1	Plasminogen Activator Inhibitor 1IBA 07/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2012
1	Immunoglobulin G (IgG)IBA 01/2012
1	Antihypertensive Agents (Antihypertensives)IBA 01/2012
1	AlbuminsIBA 01/2012
1	Immunoglobulin M (IgM)IBA 01/2012
1	GlycosaminoglycansIBA 01/2012
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 12/2011
1	Thyroxine (Levothyroxine)FDA LinkGeneric 12/2011
1	Integrin beta3 (GPIIIa)IBA 08/2011
1	Thromboplastin (Tissue Factor)IBA 08/2011
1	AntigensIBA 12/2009
1	von Willebrand FactorIBA 12/2009
1	Metalloproteases (Metalloproteinases)IBA 12/2009

Therapy/Procedure

4	Therapeutics 11/2013 - 03/2002
2	Lasers (Laser) 10/2021 - 10/2008
2	Glycemic Control 01/2021 - 02/2012
2	Intravenous Infusions 06/2015 - 10/2008
2	Subcutaneous Injections 01/2007 - 09/2003
1	Aftercare (After-Treatment) 12/2009